APP and Alzheimer disease: Aggregated Aβ peptides, hydroxyl radicals created by H2O2, and mitochondrial dysfunction caused by APP in Alzheimer's disease may be mitigated by pharmaceutical methods including phytochemicals which maintain mitochondrial dynamics.